Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Assets (2016 - 2025)

Enanta Pharmaceuticals' Return on Assets history spans 13 years, with the latest figure at 0.23% for Q4 2025.

  • For Q4 2025, Return on Assets rose 6.0% year-over-year to 0.23%; the TTM value through Dec 2025 reached 0.23%, up 6.0%, while the annual FY2025 figure was 0.25%, 3.0% up from the prior year.
  • Return on Assets reached 0.23% in Q4 2025 per ENTA's latest filing, up from 0.28% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.19% in Q1 2021 to a low of 0.45% in Q2 2022.
  • Average Return on Assets over 5 years is 0.31%, with a median of 0.31% recorded in 2023.
  • Peak YoY movement for Return on Assets: dropped -27bps in 2021, then rose 13bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.39% in 2021, then grew by 15bps to 0.33% in 2022, then increased by 7bps to 0.31% in 2023, then rose by 5bps to 0.29% in 2024, then increased by 20bps to 0.23% in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Return on Assets are 0.23% (Q4 2025), 0.28% (Q3 2025), and 0.3% (Q2 2025).